205 related articles for article (PubMed ID: 19746444)
1. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.
Nathan SS; Pereira BP; Zhou YF; Gupta A; Dombrowski C; Soong R; Pho RW; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
Mol Biol Rep; 2009 Jan; 36(1):153-8. PubMed ID: 18931939
[TBL] [Abstract][Full Text] [Related]
3. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
5. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
[TBL] [Abstract][Full Text] [Related]
6. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
7. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M
Cell Prolif; 2007 Aug; 40(4):532-49. PubMed ID: 17635520
[TBL] [Abstract][Full Text] [Related]
8. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
[TBL] [Abstract][Full Text] [Related]
9. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
10. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
11. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
12. The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.
Quist T; Jin H; Zhu JF; Smith-Fry K; Capecchi MR; Jones KB
Oncogene; 2015 Aug; 34(32):4278-84. PubMed ID: 25347737
[TBL] [Abstract][Full Text] [Related]
13. RUNX2 regulates the effects of TNFalpha on proliferation and apoptosis in SaOs-2 cells.
Olfa G; Christophe C; Philippe L; Romain S; Khaled H; Pierre H; Odile B; Jean-Christophe D
Bone; 2010 Apr; 46(4):901-10. PubMed ID: 20053387
[TBL] [Abstract][Full Text] [Related]
14. Positivity of the proliferation marker Ki-67 in noncycling cells.
van Oijen MG; Medema RH; Slootweg PJ; Rijksen G
Am J Clin Pathol; 1998 Jul; 110(1):24-31. PubMed ID: 9661919
[TBL] [Abstract][Full Text] [Related]
15. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
17. [MicroRNA-150 inhibits osteosarcoma cell proliferation by targeting RUNX2 gene].
Wang L; Wang W; Li J; Chen S; Zhan R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1285-1290. PubMed ID: 28070040
[TBL] [Abstract][Full Text] [Related]
18. A role for the retinoblastoma protein as a regulator of mouse osteoblast cell adhesion: implications for osteogenesis and osteosarcoma formation.
Sosa-García B; Gunduz V; Vázquez-Rivera V; Cress WD; Wright G; Bian H; Hinds PW; Santiago-Cardona PG
PLoS One; 2010 Nov; 5(11):e13954. PubMed ID: 21085651
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
